Transcript

Operator

Good morning, ladies and gentlemen, and welcome to DocMorris AG's conference call on the half year results for 2026. This conference is being recorded. At this time, all participants have been placed on a listen-only mode. The floor will be open for questions following the presentation. If you would like to ask a question, then you could press Star, nine, and Pound key on your telephone keypad, or use the dial-in function in the webcast and raise your hand. Let me now turn the floor over to your host, Walter Hess, CEO.

Walter Hess — CEO

Yes, thanks a lot. Welcome everybody to our H1 2026 results conference call. Today with me is Daniel, our CFO, and I'm Walter Hess, the CEO. The H1 of 2026 has been a milestone period for DocMorris, marked by accelerated growth and an outstanding operational execution. Our focus remains on scaling our integrated digital and AI-driven healthcare platform to deliver long-term profitable value. Today's agenda foresees the highlights of H1 to start with, followed by the business update, financial update, and the outlook before we move then to the Q&A session. Let's start with our highlights on slide number four. We delivered a 38% Rx growth in H1, accelerating further to 46% in Q2, with an even stronger momentum continuing into July and August. Our active customer base expanded by 1.1 million year-over-year to 12.9 million, with TeleClinic contributing 1.5 million active users. Digital services grew 71% in H1 and even 80% in Q2, translating directly into a lower proportionate profit increase due to the high margins. The execution of our AI-First strategy is fully on track, expecting a positive earnings contribution in H2 2026 and over CHF 15 million in recurring annual net savings by end of 2027. Therefore, on the back of this strong commercial momentum, we have confidently raised our full year 2026 financial guidance. DocMorris has successfully transitioned into a unique integrated digital and AI health platform serving the 12.9 million active customers. Our high volume online pharmacy remains the core engine, driving the distribution of prescribed medication as well as over-the-counter medication. Our Marketplace extends our reach by offering a comprehensive range of health products and health services through trusted partners. TeleClinic, our telemedicine platform, represents a fast-growing, highly scalable take rate business model that